Global Biobanking Market – Industry Trends and Forecast to 2027

  • Medical Devices
  • Upcoming Report
  • Dec 2019
  • Global
  • 350 Pages
  • No of Tables: 60
  • No of Figures: 220

Global Biobanking Market By Product and Services (Equipment, Consumables, Service, Software), Sample Type (Blood Products, Human Tissue, Cell Lines, Nucleic Acids, Biological Fluids, Human Waste Products), Storage Type (Manual Storage, Automated Storage), Application (Regenerative Medicine, Life Science Research, Clinical Research), Type of Biobank (Population based Biobanks, Disease- Oriented Biobanks), Ownership (National/Regional Agencies, Nonprofit Organization, University, Private), Country (U.S., Canada, Mexico, Brazil, Argentina, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa), Market Share Forecast to 2027

Market Analysis and Insights: Global Biobanking Market

Biobanking market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to USD 3.53 billion by 2027 growing at a CAGR of 5.60% in the above-mentioned forecast period. Increasing focus on the R&D of cell therapies and increasing cases of chronic diseases are the factor for the biobanking market growth in the forecast period of 2020 to 2027.

Biobank is a kind of a biorespository which is specially designed so they can store biological samples which can be later used for the research purposes so they can enhance the information associated with the different diseases and health. These samples can be human cells, blood, biological fluids, human waste products, and other.

Rising genomic research activities are the factor for the market growth. Government is also making many initiatives to support regenerative medicine research which will also enhance the market demand. There increase in the demand for cost effective drug delivery & development which will also accelerate the market growth. Advancement in the regenerative medicine will also drive the market. On the other hand, increasing research collaboration and changes in the biobanking operations will also contribute as a factor for the growth of the biobanking market in the forecast period of 2020 to 2027.

On the other hand, high price of the automation, complexity associated with the biospecimen sample procurement and regulatory issues are some of the factors hampering the growth of the biobanking market.

This biobanking market report provides details of market share, new developments, product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief our team will help you create a revenue impact solution to achieve your desired goal.

Global Biobanking Market Scope and Market Size

Biobanking market is segmented of the basis of product & services, sample type, storage type, application, type of biobank and ownership. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

On the basis of product & services, the biobanking market is segmented into equipment, consumables, service and software. The equipment segment is divided into storage equipment, sample analysis equipment, sample processing equipment and sample transport equipment. The consumables segment is further divided into storage consumables, analysis consumables, processing consumables, and collection comsumables. Service segment of the biobanking market is segmented into storage service, processing services, transport services, and supply services.

The biobanking market is also segmented on the basis of sample type into blood products, human tissue, cell lines, nucleic acids, biological fluids and human waste products.

Based on storage type, the biobanking market is segmented into manual storage and automated storage.

Application segment of the biobanking market is divided into regenerative medicine, life science research and clinical research.

On the basis of type of biobank, the market is segmented into population based biobanks and disease- oriented biobanks.

Ownership segment of the biobanking market is segmented into national/regional agencies, nonprofit organization, university and private.

Biobanking Market Country Level Analysis

Biobanking market is analysed and market size insights and trends are provided product & services, sample type, storage type, application, type of biobank and ownership as referenced above.

The countries covered in the biobanking market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific in the Asia-Pacific, Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa as a part of Middle East and Africa, Brazil, Argentina and Rest of South America as part of South America.

North America dominates the biobanking market, while Asia-Pacific is expected to grow at the highest growth rate in the forecast period 2020 to 2027 due to increasing government investment in biomedical and biotechnology industries.

The country section of the biobanking market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands impact of sales channels are considered while provided forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

Biobanking market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for biobanking market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the biobanking market. The data is available for historic period 2010 to 2018.

Competitive Landscape and Biobanking Market Share Analysis

Biobanking market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to biobanking market.

The major players covered in the biobanking market report are Thermo Fisher Scientific Inc, Tecan Trading AG, QIAGEN, Hamilton Company., Brooks Life Sciences, TTP Labtech, VWR International, LLC, Promega Corporation, Worthington Industries, BD, Merck KGaA, Biokryo GmbH, Cell&Co BioServices, RUCDR Infinite Biologics, Modul-Bio, STEMCELL Technologies Inc, BioLifeSolutions Inc., BioCision., Taylor-Wharton.,among other players domestic and global. Market Share data is available for Global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Customization Available : Global Biobanking Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

Please fill in the below form for detailed Table of Content

Please fill in the below form for detailed List of Table

Please fill in the below form for detailed List of Figure

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
BUY NOW ADD TO CART
Why Choose Us
REQUEST FOR SAMPLE